Broad Clinical Labs (BCL), a wholly owned subsidiary of the Broad Institute of MIT and Harvard, brings the Institute’s world-class genomics expertise into a clinical setting. By bridging research and clinical application, BCL enables large-scale studies, direct-to-patient research programs, and collaborations that accelerate discovery and improve patient outcomes. The lab’s rigorous standards, advanced technologies, and mission-driven approach empower scientists and partners to translate genomic insights into real-world impact for patients everywhere.
MassBio Member Spotlight: Broad Clinical Labs (BCL)
Location: 27 Blue Sky Drive Burlington, MA
Business Type: CLIA-certified, CAP-accredited clinical laboratory that provides high-quality genomic testing and data generation services to advance translational research and precision medicine. BCL supports a broad range of therapeutic areas through comprehensive sequencing, bioinformatics, and clinical laboratory expertise.
Leadership (full list):
- Niall Lennon, Ph.D., Chair and Chief Scientific Officer
- Heidi Rehm, Ph.D., FACMG, Chief Medical Officer and Clinical Laboratory Director
- Sean Hofherr, Chief of Clinical Strategy and Product Development
Website: broadclinicallabs.org
